Application of Whole-course Standardized Nutrition Management During Peri-radiotherapy in Patients With Nasopharyngeal Carcinoma After Radiotherapy: a Multicenter Randomized Controlled Clinical Study
NCT05008471 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 388
Last updated 2021-08-17
Summary
This study will present an advanced equipment of tumor nutrition diagnosis and assesment for nasopharyngeal cancer(NPC) radiotherapy patients in nutritional risk screening, evaluation, diagnosis and directing nutritional intervention, aiming to explore the advantages of the whole nutritional management in acute radiation reaction rate, completion rate of radiotherapy, nutritional status, and quality of life for NPC patients.
Conditions
- Nasopharyngeal Carcinoma
- Radiation Therapy Induced Change
- Nutrition Disorders
Interventions
- DIETARY_SUPPLEMENT
-
Formula nutrition
The target energy of radiotherapy patients is recommended to be 25-30kcal/(kg·d), and the target energy of the intervention group should be increased by an additional 50% daily from the beginning of radiotherapy. Specifically, under the condition of ensuring the daily target energy 14kcal/(kg·d), formula nutrition should be added daily.
Sponsors & Collaborators
-
First Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
Second Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
Sun Yat-sen University
lead OTHER
Principal Investigators
-
Yunfei Xia, MD · Sun Yat-sen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-26
- Primary Completion
- 2022-04-26
- Completion
- 2022-04-26
Countries
- China
Study Locations
More Related Trials
-
Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
NCT05780372 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
NCT04636632 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma
NCT02111460 ·Status: UNKNOWN ·Phase: PHASE3
-
Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma
NCT05741008 ·Status: COMPLETED ·Phase: NA
-
Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT02434614 ·Status: UNKNOWN ·Phase: PHASE3
-
Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.
NCT06533267 ·Status: RECRUITING ·Phase: NA
-
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC
NCT07332247 ·Status: RECRUITING ·Phase: PHASE2
-
To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal Carcinoma
NCT03346109 ·Status: UNKNOWN ·Phase: NA
-
Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT00677118 ·Status: UNKNOWN ·Phase: PHASE3
-
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
NCT05941741 ·Status: RECRUITING ·Phase: PHASE3
-
Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC
NCT03503136 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients
NCT03353467 ·Status: RECRUITING ·Phase: NA
-
Nedaplatin in Treatment for Nasopharyngeal Carcinoma
NCT04834206 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy
NCT05622474 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Individualized Elective Neck Irradiation Based on MRI in NPC Patients
NCT02642107 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients
NCT02604472 ·Status: COMPLETED
-
Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT04414566 ·Status: UNKNOWN ·Phase: PHASE3
-
GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma
NCT06455410 ·Status: RECRUITING ·Phase: PHASE2
-
Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma
NCT03668730 ·Status: UNKNOWN ·Phase: PHASE2
-
Adaptive Immunotherapy for Nasopharyngeal Carcinoma
NCT07154069 ·Status: RECRUITING ·Phase: PHASE3
-
Whole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal Carcinoma
NCT05431764 ·Status: RECRUITING ·Phase: PHASE2
-
Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC
NCT03366415 ·Status: UNKNOWN ·Phase: PHASE3
-
Prospective Comparisons of Clinical Trial and Real-world Outcomes in Nasopharyngeal Carcinoma
NCT04108338 ·Status: COMPLETED
-
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC
NCT07235319 ·Status: RECRUITING ·Phase: PHASE3
-
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
NCT07328841 ·Status: RECRUITING ·Phase: PHASE3